Verona Pharma PLC (VRNA)
15.55
+0.24
(+1.57%)
USD |
NASDAQ |
Apr 26, 11:27
Verona Pharma Market Cap: 1.257B for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 1.237B |
| April 24, 2024 | 1.232B |
| April 23, 2024 | 1.260B |
| April 22, 2024 | 1.270B |
| April 19, 2024 | 1.270B |
| April 18, 2024 | 1.301B |
| April 17, 2024 | 1.325B |
| April 16, 2024 | 1.309B |
| April 15, 2024 | 1.277B |
| April 12, 2024 | 1.286B |
| April 11, 2024 | 1.307B |
| April 10, 2024 | 1.315B |
| April 09, 2024 | 1.331B |
| April 08, 2024 | 1.364B |
| April 05, 2024 | 1.375B |
| April 04, 2024 | 1.337B |
| April 03, 2024 | 1.312B |
| April 02, 2024 | 1.287B |
| April 01, 2024 | 1.297B |
| March 28, 2024 | 1.300B |
| March 27, 2024 | 1.333B |
| March 26, 2024 | 1.304B |
| March 25, 2024 | 1.270B |
| March 22, 2024 | 1.299B |
| March 21, 2024 | 1.289B |
| Date | Value |
|---|---|
| March 20, 2024 | 1.287B |
| March 19, 2024 | 1.236B |
| March 18, 2024 | 1.255B |
| March 15, 2024 | 1.265B |
| March 14, 2024 | 1.256B |
| March 13, 2024 | 1.349B |
| March 12, 2024 | 1.332B |
| March 11, 2024 | 1.286B |
| March 08, 2024 | 1.312B |
| March 07, 2024 | 1.352B |
| March 06, 2024 | 1.359B |
| March 05, 2024 | 1.371B |
| March 04, 2024 | 1.396B |
| March 01, 2024 | 1.470B |
| February 29, 2024 | 1.392B |
| February 28, 2024 | 1.395B |
| February 27, 2024 | 1.447B |
| February 26, 2024 | 1.425B |
| February 23, 2024 | 1.333B |
| February 22, 2024 | 1.351B |
| February 21, 2024 | 1.335B |
| February 20, 2024 | 1.368B |
| February 16, 2024 | 1.384B |
| February 15, 2024 | 1.347B |
| February 14, 2024 | 1.404B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.44M
Minimum
Mar 18 2020
1.976B
Maximum
Dec 30 2022
623.95M
Average
381.85M
Median
Market Cap Benchmarks
| NuCana PLC | 8.479M |
| TC BioPharm (Holdings) PLC | 5.016M |
| Biodexa Pharmaceuticals Plc | 5.722M |
| Adaptimmune Therapeutics PLC | 264.10M |
| Biophytis SA | 2.780M |
Market Cap Related Metrics
| Price to Book Value | 5.041 |
| Price | 15.55 |
| Earnings Yield | -4.63% |